Literature DB >> 31272990

Acute psychosis in glycogen storage disease: a rare but severe complication.

Thomas Frederick Dunne1, Tarekegn Geberhiwot2, Rowena Jones3.   

Abstract

Glycogen storage disease type 1 (GSD-1) is a group of inherited metabolic disorders characterised by the inability to use intracellular glucose stores. It is associated with a high risk of hypoglycaemia, as well as long-term complications including growth retardation, hepatocellular adenomas, renal disease, hypertriglyceridaemia and hyperuricaemia. Treatment involves slow absorption carbohydrates, for example, cornstarch. We present a case of acute psychosis in a patient with GSD-1a. This was initially attributed to his opiate use. Later in his management an MRI scan of his head was performed which revealed regions of brain atrophy following significant hypoglycaemic insult, thus identifying an organic cause of his psychosis. This case presents a rare complication of glycogen storage disease: organic psychosis attributable to cortical atrophy from profound hypoglycaemic insult. It emphasises the importance of investigating organic causes of psychiatric symptoms. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  metabolic disorders; neurological injury; psychotic disorders (incl schizophrenia)

Mesh:

Year:  2019        PMID: 31272990      PMCID: PMC6613960          DOI: 10.1136/bcr-2017-222307

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  Cornstarch therapy in type I glycogen-storage disease.

Authors:  Y T Chen; M Cornblath; J B Sidbury
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

2.  Brain atrophy is a frequent finding in elderly patients with first episode psychosis.

Authors:  Ulla-Marja Louhija; Tuula Saarela; Kati Juva; Björn Appelberg
Journal:  Int Psychogeriatr       Date:  2017-06-07       Impact factor: 3.878

3.  Severe pulmonary arterial hypertension in type 1 glycogen storage disease.

Authors:  Marc Humbert; Philippe Labrune; Gérald Simonneau
Journal:  Eur J Pediatr       Date:  2002-07-31       Impact factor: 3.183

4.  Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease.

Authors:  David A Weinstein; Joseph I Wolfsdorf
Journal:  Eur J Pediatr       Date:  2002-07-31       Impact factor: 3.183

5.  Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence.

Authors:  Gerhard Däublin; Bernd Schwahn; Udo Wendel
Journal:  Eur J Pediatr       Date:  2002-08-22       Impact factor: 3.183

6.  Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia.

Authors:  Leonardo Bonilha; Chris Molnar; Michael D Horner; Berry Anderson; Lauren Forster; Mark S George; Ziad Nahas
Journal:  Schizophr Res       Date:  2007-12-31       Impact factor: 4.939

7.  Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.

Authors:  J L Cohen; A Vinik; J Faller; I H Fox
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

8.  Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.

Authors:  Priya S Kishnani; Stephanie L Austin; Jose E Abdenur; Pamela Arn; Deeksha S Bali; Anne Boney; Wendy K Chung; Aditi I Dagli; David Dale; Dwight Koeberl; Michael J Somers; Stephanie Burns Wechsler; David A Weinstein; Joseph I Wolfsdorf; Michael S Watson
Journal:  Genet Med       Date:  2014-11       Impact factor: 8.822

9.  Acute psychotic disorder and hypoglycemia.

Authors:  S K Singh; J K Agrawal; A S Srivastava; V K Bhardwaj; B S Bose
Journal:  Indian J Psychiatry       Date:  1994-04       Impact factor: 1.759

10.  Hallucinations: Clinical aspects and management.

Authors:  Suprakash Chaudhury
Journal:  Ind Psychiatry J       Date:  2010-01
View more
  2 in total

1.  A New Perspective on the Quality of Life of Children with Glycogen Storage Diseases.

Authors:  Gihan Ahmed Sobhy; Mortada El-Shabrawi; Heba Safar
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-07-06

Review 2.  Psychopharmacological Treatments for Mental Disorders in Patients with Neuromuscular Diseases: A Scoping Review.

Authors:  Chiara Brusa; Giulio Gadaleta; Rossella D'Alessandro; Guido Urbano; Martina Vacchetti; Chiara Davico; Benedetto Vitiello; Federica S Ricci; Tiziana E Mongini
Journal:  Brain Sci       Date:  2022-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.